Publications
30
Citations
222
Est. group size
~2
Recurring co-author estimate
Active years
16
Publishing since 2011
Pamela Burcham's work focuses on the clinical management of patients undergoing solid organ transplantation, especially lung and heart transplants, including immunosuppression drug therapy, rejection management, and infection prevention. Much of the research addresses practical medication and treatment questions faced by transplant teams, such as antibiotic duration, anticoagulation strategies, and drug dosing in critically ill patients. This work would suit students interested in clinical pharmacy or applied research on post-transplant patient care rather than basic laboratory science.
Publication output has been modest and somewhat variable over the last decade, with a dip in 2022 followed by a notable increase in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 26-CVT-15776-ACC A DESCRIPTIVE ANALYSIS OF PROTEOSOME INHIBITOR THERAPY FOR ANTIBODY-MEDIATED REJECTION IN CARDIAC TRANSPLANTATION
Journal of the American College of Cardiology · 2026
- Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation
JHLT Open · 2025
- Initiation and Observation of a Novel Treatment Paradigm to Optimize Bone Mineral Density
The Journal of Heart and Lung Transplantation · 2025
- Corrigendum to ‘‘Sotatercept use in a patient with pulmonary arterial hypertension undergoing lung transplantation’’ [JHLT Open (2025) 100213]
JHLT Open · 2025
- Efficacy of Short Course Direct Acting Antivirals and Ezetimibe vs Longer Course of Direct Acting Antivirals to Prevent Hepatitis C Infection in Thoracic Transplant Recipients of Hepatitis C Viremic Donors
The Journal of Heart and Lung Transplantation · 2024
- Lung Allograft Function and Clinical Outcomes Following Treatment for Antibody Mediated Rejection
2024
- (659) Post COVID Pulmonary Necrosis and Polymicrobial Empyema Managed with Bilateral Lung Transplantation and Post-Transplant Local and Parenteral Antibiotics
The Journal of Heart and Lung Transplantation · 2023
- (693) Infection with Covid Variants of Concern in a Lung Transplant Population
The Journal of Heart and Lung Transplantation · 2023
- Calcineurin Inhibitor–Based Maintenance Immunosuppression in Lung Transplant Recipients: Optimal Serum Levels for Managing Acute Rejection and Renal Function
Transplantation Proceedings · 2021
- Tu1439 ESOPHAGEAL DYSFUNCTION IS PREVALENT FOLLOWING LUNG TRANSPLANTATION
Gastroenterology · 2020
- Effectiveness of short vs long‐course perioperative antibiotics in lung transplant recipients with donor positive respiratory cultures
Transplant Infectious Disease · 2020
- 575. Effectiveness of Short vs Long Course Perioperative Antibiotics in Lung Transplant Recipients with Donor Positive Respiratory Cultures
Open Forum Infectious Diseases · 2020
- Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy
Perfusion · 2019
- Risk Factors and Outcomes Associated with Prolonged Subtherapeutic Anticoagulation with Bivalirudin: A Retrospective Cohort Study
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2019
- Correction to: Immunosuppression Drug Therapy in Lung Transplantation for Cystic Fibrosis
Pediatric Drugs · 2018
- The Journal of Heart and Lung Transplantation×6
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy×2
- JHLT Open×2
- Pediatric Drugs×2
- International Journal of Critical Illness and Injury Science×1
- Asvin M. Ganapathi
Medicine · The Ohio State University
- Verai Ramsammy
Medicine · The Ohio State University
- Deipanjan Nandi
Medicine · The Ohio State University
- Bryan A. Whitson
Medicine · The Ohio State University
- Kukbin Choi
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile